Join
Live feed
·
PRReleasevia Quantisnow
IDEAYA Biosciences Inc. logo

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

ByQuantisnow·Wall Street's wire, on your screen.
IDYA· IDEAYA Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IDYA (IDEAYA Biosciences Inc.) and more on Quantisnow.